Business Context and Reporting Period
This Form 6-K filing by Microalgo Inc. (a foreign private issuer) covers the month of October 2024, with the report dated October 9, 2024. The filing discloses a material corporate transaction involving the issuance of unsecured convertible promissory notes to certain investors.
Key Financial Metrics
The filing details a specific financing event rather than periodic financial performance metrics. Key figures include:
- Aggregate Principal Amount: $20,000,000
- Original Issue Discount (OID): $1,600,000
- Note Term: 360 days (commencing October 8, 2024)
- Default Interest Rate: 10% per annum
- Transaction Costs: Borne by the Company
The filing text does not provide clear values for revenue, profit, cash flow, margins, existing debt levels, or liquidity ratios outside of this specific transaction.
Material Changes
The primary material change is the execution of Convertible Note Purchase Agreements on October 7, 2024, and the subsequent issuance of Notes on October 8, 2024. This transaction increases the company's debt obligations by $20 million, subject to conversion into ordinary shares.
Guidance, Outlook, and Risks
Use of Proceeds: Net proceeds will be utilized for working capital and general corporate purposes.
Conversion Terms: Investors may convert notes into ordinary shares at a price equal to 70% of the lowest market closing price of the company's ordinary shares in the 60 trading days preceding the conversion request.
Ownership Limitation: The company may decline conversions if they would cause an investor to beneficially own more than 9.99% of the outstanding ordinary shares.
Risks and Contingencies: An Event of Default triggers a 10% annual interest rate accrual. The filing notes that the summary of terms is qualified by the full Purchase Agreements and Notes attached as exhibits.
Investor Verification Checklist
- Verify the exact number of ordinary shares outstanding to assess the dilution impact of the 9.99% ownership limitation.
- Review the full Convertible Note Purchase Agreement (Exhibit 99.1) and Note form (Exhibit 99.2) for specific default triggers and covenants.
- Confirm the company's current cash position to evaluate the necessity of the $20 million working capital injection.
- Monitor the stock price volatility over the 60-day window preceding any potential conversion to understand the effective conversion price.